- Country: Russia
- Summary: Purchase of the Drug Abacavir for the Prevention and Treatment of Patients with Hiv Infections, Opportunistic, Aids-Associated and Concomitant Diseases (L234466)
- RUT Ref No: 92114297
- Deadline: 20 Nov 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 148008.00
- Notice Type: Tender
- Document Ref. No.: 0348200081023002903
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase of the drug Abacavir for the prevention and treatment of patients with HIV infections, opportunistic, AIDS-associated and concomitant diseases (L234466)
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of the Drug Abacavir for the Prevention and Treatment of Patients with Hiv Infections, Opportunistic, Aids-Associated and Concomitant Diseases (L234466) - Russia Tender
The STATE PUBLIC INSTITUTION OF THE MOSCOW REGION "DIRECTORATE OF THE SINGLE CUSTOMER OF THE MINISTRY OF HEALTH OF THE MOSCOW REGION, a Government sector organization in Russia, has announced a new tender for Purchase of the Drug Abacavir for the Prevention and Treatment of Patients with Hiv Infections, Opportunistic, Aids-Associated and Concomitant Diseases (L234466). This tender is published on RussiaTenders under RUT Ref No: 92114297 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-11-20.
The estimated tender value is RUB 148008.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
